PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer
Clicks: 149
ID: 274468
2006
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
30.0
/100
148 views
7 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Prostate cancer (PrCa) is characterized by progression from an androgen-dependent phenotype to one that is inevitably androgen independent (AI) and lethal. Recent evidence strongly suggests that the phosphatidylinositol-3-kinase/Akt (PI3K/Akt) and androgen receptor (AR) signalling pathways provide p …
| Reference Key |
dj2006oncogenepten
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mulholland DJ;Dedhar S;Wu H;Nelson CC;; |
| Journal | Oncogene |
| Year | 2006 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
male
disease progression
androgens / physiology*
pmid:16421604
doi:10.1038/sj.onc.1209020
d j mulholland
s dedhar
c c nelson
glycogen synthase kinase 3 / physiology*
glycogen synthase kinase 3 beta
pten phosphohydrolase / physiology*
prostatic neoplasms / physiopathology*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.